Real-Time Monitoring of Nuclear Factor κB Activity in Cultured Cells and in Animal Models

Nuclear factor κB (NF-κB) is a transcription factor that plays a major role in many human disorders, including immune diseases and cancer. We designed a reporter system based on NF-κB responsive promoter elements driving expression of the secreted Gaussia princeps luciferase (Gluc). We show that this bioluminescent reporter is a highly sensitive tool for noninvasive monitoring of the kinetics of NF-κB activation and inhibition over time, both in conditioned medium of cultured cells and in the blood and urine of animals. NF-κB activation was successfully monitored in real time in endothelial cells in response to tumor angiogenic signaling, as well as in monocytes in response to inflammation. Further, we demonstrated dual blood monitoring of both NF-κB activation during tumor development as correlated to tumor formation using the NF-κB Gluc reporter, as well as the secreted alkaline phosphatase reporter. This NF-κB reporter system provides a powerful tool for monitoring NF-κB activity in real time in vitro and in vivo.

[1]  P. Massion,et al.  IkappaB kinase-alpha regulates endothelial cell motility and tumor angiogenesis. , 2008, Cancer research.

[2]  R. Guo,et al.  Increased staining for phosphorylated AKT and nuclear factor‐κB p65 and their relationship with prognosis in epithelial ovarian cancer , 2008, Pathology international.

[3]  R. Weissleder,et al.  miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. , 2008, Cancer cell.

[4]  P. Korkolopoulou,et al.  Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival. , 2008, Human pathology.

[5]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[6]  Ralph Weissleder,et al.  A secreted luciferase for ex vivo monitoring of in vivo processes , 2008, Nature Methods.

[7]  Howard E. Gendelman,et al.  Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease , 2007, Proceedings of the National Academy of Sciences.

[8]  R. Svensson,et al.  Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy. , 2007, Cancer research.

[9]  B. Bejcek,et al.  NF-κB controls growth of glioblastomas/astrocytomas , 2007, Molecular and Cellular Biochemistry.

[10]  X. Breakefield,et al.  A Highly Sensitive Assay for Monitoring the Secretory Pathway and ER Stress , 2007, PloS one.

[11]  C. Gondi,et al.  Transfection with Anti-p65 Intrabody Suppresses Invasion and Angiogenesis in Glioma Cells by Blocking Nuclear Factor-κB Transcriptional Activity , 2007, Clinical Cancer Research.

[12]  M. García-Carrasco,et al.  The transcription factor nuclear factor-kappa B and cancer. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[13]  R. Martuza,et al.  Treatment of Implantable NF2 Schwannoma Tumor Models with Oncolytic Herpes Simplex Virus G47Δ , 2007, Cancer Gene Therapy.

[14]  N. Sun,et al.  Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer. , 2006, The Annals of thoracic surgery.

[15]  M. Karin Nuclear factor-κB in cancer development and progression , 2006, Nature.

[16]  K. F. Perry,et al.  Metabolic biotinylation of cell surface receptors for in vivo imaging , 2006, Nature Methods.

[17]  S. Ghosh,et al.  Role of nuclear factor‐κB in the immune system and bone , 2005 .

[18]  Michael Karin,et al.  NF-κB: linking inflammation and immunity to cancer development and progression , 2005, Nature Reviews Immunology.

[19]  David Piwnica-Worms,et al.  Real-time imaging of ligand-induced IKK activation in intact cells and in living mice , 2005, Nature Methods.

[20]  H. Duan,et al.  Histone Deacetylase Inhibitors Down-Regulate bcl-2 Expression and Induce Apoptosis in t(14;18) Lymphomas , 2005, Molecular and Cellular Biology.

[21]  R. Weissleder,et al.  Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  T. Crombleholme,et al.  Optimized large-scale production of high titer lentivirus vector pseudotypes. , 2004, Journal of virological methods.

[23]  D. Brenner,et al.  In Vivo Pattern of Lipopolysaccharide and Anti-CD3-Induced NF-κB Activation Using a Novel Gene-Targeted Enhanced GFP Reporter Gene Mouse1 , 2004, The Journal of Immunology.

[24]  Pingfu Fu,et al.  Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. , 2004, Neoplasia.

[25]  S. Shukla,et al.  Suppression of Constitutive and Tumor Necrosis Factor α-Induced Nuclear Factor (NF)-κB Activation and Induction of Apoptosis by Apigenin in Human Prostate Carcinoma PC-3 Cells: Correlation with Down-Regulation of NF-κB-Responsive Genes , 2004, Clinical Cancer Research.

[26]  M. Eren,et al.  Tumor Necrosis Factor α Activates the Human Plasminogen Activator Inhibitor-1 Gene through a Distal Nuclear Factor κB Site* , 2004, Journal of Biological Chemistry.

[27]  Mark A Rizzo,et al.  An improved cyan fluorescent protein variant useful for FRET , 2004, Nature Biotechnology.

[28]  F. Meyskens,et al.  Comparative expression of NFkappaB proteins in melanocytes of normal skin vs. benign intradermal naevus and human metastatic melanoma biopsies. , 2004, Pigment cell research.

[29]  Marianne Fillet,et al.  NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells , 2003, Oncogene.

[30]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[31]  H. Ishii,et al.  Bleomycin induces E-selectin expression in cultured umbilical vein endothelial cells by increasing its mRNA levels through activation of NF-kappaB/Rel. , 2002, Toxicology and applied pharmacology.

[32]  David S. Park,et al.  Constitutive Nuclear Factor-κB Activity Is Required for Central Neuron Survival , 2002, The Journal of Neuroscience.

[33]  Xiankui Li,et al.  Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2. , 2002, International journal of oncology.

[34]  H. Carlsen,et al.  In Vivo Imaging of NF-κB Activity1 , 2002, The Journal of Immunology.

[35]  C. Bucana,et al.  Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis , 2001, Oncogene.

[36]  H. Kalthoff,et al.  Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin , 2001, Oncogene.

[37]  R. Schmid,et al.  Suppression of NF-κB activity by sulfasalazine is mediated by direct inhibition of IκB kinases α and β , 2000 .

[38]  B. Rayet,et al.  Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.

[39]  H. Pahl Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.

[40]  B. Aggarwal,et al.  VEGI, a new member of the TNF family activates Nuclear Factor-κB and c-Jun N-terminal kinase and modulates cell growth , 1999, Oncogene.

[41]  M. Neurath,et al.  Role of NF-κB in immune and inflammatory responses in the gut , 1998 .

[42]  C. Brinckerhoff,et al.  Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta-stimulated synovial fibroblasts. , 1998, Arthritis and rheumatism.

[43]  M. Odeh,et al.  Role of cytokines in rheumatoid arthritis. , 1998, Drug news & perspectives.

[44]  I. Adcock,et al.  Transcription factors and asthma. , 1998, The European respiratory journal.

[45]  R. Schmid,et al.  Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. , 1998, The Journal of clinical investigation.

[46]  A. Palotie,et al.  Genomic Organization of Human and Mouse Genes for Vascular Endothelial Growth Factor C* , 1997, The Journal of Biological Chemistry.

[47]  A. Israël,et al.  NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. , 1996, Development.

[48]  E M Schwarz,et al.  Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. , 1995, Genes & development.

[49]  H. Volk,et al.  Stimulation of the Human Cytomegalovirus IE Enhancer/Promoter in HL-60 Cells by TNFα Is Mediated via Induction of NF-κB , 1995 .

[50]  H. Vinters,et al.  Unexpected Expression of Intermediate Filament Protein Genes in Human Oligodendroglioma Cell Lines , 1995, Journal of neuropathology and experimental neurology.

[51]  G. Felsenfeld,et al.  A 5′ element of the chicken β-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila , 1993, Cell.

[52]  R. Weichselbaum,et al.  Ionizing radiation induces expression and binding activity of the nuclear factor kappa B. , 1991, The Journal of clinical investigation.

[53]  G. Nabel,et al.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[54]  David Baltimore,et al.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.

[55]  Y. Song,et al.  NF-kappaB as a potential molecular target for cancer therapy. , 2007, BioFactors.

[56]  Y. Song,et al.  NF‐κB as a potential molecular target for cancer therapy , 2007 .

[57]  M. Karin Nuclear factor-kappaB in cancer development and progression. , 2006, Nature.

[58]  T. Blackwell,et al.  Bioluminescence imaging. , 2005, Proceedings of the American Thoracic Society.

[59]  S. Shukla,et al.  Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

[60]  X. Breakefield,et al.  Improved HSV-1 amplicon packaging system using ICP27-deleted, oversized HSV-1 BAC DNA. , 2003, Methods in molecular medicine.

[61]  David S. Park,et al.  Constitutive nuclear factor-kappa B activity is required for central neuron survival. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[62]  Rune Blomhoff,et al.  In vivo imaging of NF-kappa B activity. , 2002, Journal of immunology.

[63]  R. Schmid,et al.  Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. , 2000, Gastroenterology.

[64]  H. Pahl,et al.  Activators and target genes of Rel/NF-kappaB transcription factors. , 1999, Oncogene.

[65]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[66]  K. Schulze-Osthoff,et al.  Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta. , 1998, The Journal of biological chemistry.

[67]  M. Feldmann,et al.  Role of cytokines in rheumatoid arthritis. , 1996, Annual review of immunology.

[68]  H. Volk,et al.  Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB. , 1995, Virology.

[69]  G. Nabel,et al.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells , 1990, Nature.